David Sternberg

6.2k total citations
120 papers, 4.6k citations indexed

About

David Sternberg is a scholar working on Molecular Biology, Aerospace Engineering and Oncology. According to data from OpenAlex, David Sternberg has authored 120 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Aerospace Engineering and 24 papers in Oncology. Recurrent topics in David Sternberg's work include Spacecraft Design and Technology (15 papers), Space Satellite Systems and Control (14 papers) and HER2/EGFR in Cancer Research (13 papers). David Sternberg is often cited by papers focused on Spacecraft Design and Technology (15 papers), Space Satellite Systems and Control (14 papers) and HER2/EGFR in Cancer Research (13 papers). David Sternberg collaborates with scholars based in United States, Japan and Germany. David Sternberg's co-authors include G. R. Mandels, Margaret M. Berg, Moses V. Chao, Elwyn T. Reese, Luis F. Parada, Mary Mandels, D. Gary Gilliland, Frank H. Bissett, D. Gary Gilliland and James D. Griffin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Sternberg

116 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sternberg United States 35 2.1k 1.1k 755 750 727 120 4.6k
Yong Peng China 48 7.1k 3.4× 338 0.3× 686 0.9× 1.7k 2.3× 309 0.4× 160 10.2k
Deborah V. Novack United States 43 4.5k 2.2× 384 0.4× 132 0.2× 2.6k 3.4× 230 0.3× 81 6.9k
Robert P. Wersto United States 48 4.0k 1.9× 229 0.2× 213 0.3× 1.9k 2.5× 168 0.2× 91 7.1k
Rex C. Haydon United States 40 4.4k 2.1× 843 0.8× 101 0.1× 1.3k 1.8× 102 0.1× 83 7.5k
Jesús Gil United Kingdom 54 9.7k 4.7× 323 0.3× 297 0.4× 2.2k 2.9× 305 0.4× 120 14.7k
Mo Chen China 41 4.9k 2.4× 264 0.3× 81 0.1× 958 1.3× 303 0.4× 180 7.5k
Kazuhito Naka Japan 40 4.0k 1.9× 105 0.1× 187 0.2× 2.0k 2.7× 1.1k 1.6× 92 7.3k
Terry Van Dyke United States 40 4.5k 2.2× 251 0.2× 638 0.8× 3.0k 3.9× 125 0.2× 104 7.2k
Mari Cleide Sogayar Brazil 39 2.4k 1.1× 498 0.5× 62 0.1× 592 0.8× 111 0.2× 175 5.1k
Raffaele Calogero Italy 47 5.5k 2.7× 178 0.2× 120 0.2× 1.2k 1.6× 560 0.8× 183 8.3k

Countries citing papers authored by David Sternberg

Since Specialization
Citations

This map shows the geographic impact of David Sternberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sternberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sternberg more than expected).

Fields of papers citing papers by David Sternberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sternberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sternberg. The network helps show where David Sternberg may publish in the future.

Co-authorship network of co-authors of David Sternberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Sternberg. A scholar is included among the top collaborators of David Sternberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sternberg. David Sternberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steuer, Conor, Hidetoshi Hayashi, Wu‐Chou Su, et al.. (2025). Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy. Journal of Clinical Oncology. 43(25). 2816–2826. 3 indexed citations
2.
Majumdar, Rwitajit, et al.. (2025). Demonstration of the Dyna Reinforcement Learning Framework for Reactive Close Proximity Operations. Deep Blue (University of Michigan).
4.
Sternberg, David, et al.. (2024). Psyche Mission System Level Guidance, Navigation, and Control Off-Nominal Testing. 1–14. 1 indexed citations
5.
Harfouch, Omar, Andrea Lisco, Ashley Davis, et al.. (2024). High Rates of High-risk HPV Anal Infection and Abnormal Cytology in a Cohort of Transgender People Assigned Male at Birth. Open Forum Infectious Diseases. 11(12). ofae662–ofae662. 2 indexed citations
6.
Powles, Thomas, Aakanksha Bhatia, Barbara Burtness, et al.. (2024). 690TiP HERTHENA-PanTumor01: A global phase II trial of HER3-DXd in metastatic solid tumors. Annals of Oncology. 35. S534–S535. 2 indexed citations
7.
Jänne, Pasi A., Kiyotaka Yoh, SH Lee, et al.. (2023). 1319MO Intracranial efficacy of HER3-DXd in patients with previously treated advanced EGFR-mutated NSCLC: Results from HERTHENA-Lung01. Annals of Oncology. 34. S760–S761. 4 indexed citations
9.
Iwata, Hiroji, Ian E. Krop, Norikazu Masuda, et al.. (2023). PS2-4 Phase 1/2 study of HER3-DXd in HER3-expressing metastatic breast cancer: Subgroup analysis by HER2 expression. Annals of Oncology. 34. S1379–S1379. 2 indexed citations
10.
Sternberg, David, et al.. (2020). Lunar Flashlight CubeSat GNC system development. Acta Astronautica. 173. 425–441. 11 indexed citations
11.
Cooper, Dennis, Deepu Madduri, Suzanne Lentzsch, et al.. (2019). Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3176–3176. 31 indexed citations
12.
Baker, John M., et al.. (2019). MarCO: The First Interplanetary CubeSats. EPSC. 2019. 1 indexed citations
13.
Reiter, Alfred, Hanneke C. Kluin‐Nelemans, Cem Akin, et al.. (2017). Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls. Haematologica. 7 indexed citations
14.
Saura, Cristina, Johanna C. Bendell, Guy Jérusalem, et al.. (2014). Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy. Clinical Cancer Research. 20(7). 1935–1945. 110 indexed citations
16.
Radomska, Hanna S., Daniela S. Daniela Sanchez Bassères, Rui Zheng, et al.. (2006). Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. The Journal of Experimental Medicine. 203(2). 371–381. 161 indexed citations
17.
Licht, Jonathan D. & David Sternberg. (2005). The Molecular Pathology of Acute Myeloid Leukemia. Hematology. 2005(1). 137–142. 41 indexed citations
18.
Levine, Ross L., Martha Wadleigh, David Sternberg, et al.. (2004). KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). Leukemia. 19(1). 27–30. 46 indexed citations
19.
Bassères, Daniela S. Daniela Sanchez, Hanna S. Radomska, David Sternberg, et al.. (2003). Differentiation block in FLT3 mutant AML by inactivation of C/EBPalpha function by phosphorylation. Blood. 102(11). 17216. 1 indexed citations
20.
Sternberg, David. (1976). Production of cellulase by Trichoderma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35–53. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026